NCT01539356已完成不适用
Hepcidin Levels in Preterm Infants Receiving Blood Transfusion and During Sepsis.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 62
- 试验地点
- 1
- 主要终点
- Increase in Hepcidin levels by 30%
研究概览
简要总结
A recently isolated peptide hormone, hepcidin, is thought to be the principal regulator of iron homeostasis. Hepcidin acts by limiting intestinal iron absorption and promoting iron retention in reticuloendothelial cells. The aims of this study were to determine serum hepcidin levels in preterm infants who receive blood transfusion and preterm infants having sepsis, in order to assess possible relationships between hepcidin and serum iron, serum ferritin,in iron load situations.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 24 Weeks 至 37 Weeks（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Preterm < 38 weeks gestation
- •Need of blood test for anemia or suspected sepsis
排除标准
- •Major congenital anomalies
- •Birth Asphyxia
结局指标
主要结局
Increase in Hepcidin levels by 30%
时间窗: within 24-72 h
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
The Role of Hepcidin as a Biomarker to Predict Successful Renal TransplantationEnd-stage Renal DiseaseNCT04575077Yonsei University200
已完成
不适用
Study of Serum Hepcidin Rate Variations During Menstrual CycleHealthy WomenNCT01764412Rennes University Hospital147
已完成
不适用
Serum Hepcidin in Pregnant Women and the Association With Pregnancy OutcomeAnemiaNCT03792464University Hospital, Basel, Switzerland188
已完成
不适用
Assessement of Hepcidin in Saliva in Human VolunteersHepcidin, SalivaNCT03816813Swiss Federal Institute of Technology90
尚未招募
不适用
Hepcidin After Intravenous Iron TreatmentIron Deficiency (Without Anemia)NCT06264687Pierre-Alexandre Krayenbühl10